Literature DB >> 11714543

Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells.

K Fukuoka1, H Arioka, Y Iwamoto, H Fukumoto, H Kurokawa, T Ishida, A Tomonari, T Suzuki, J Usuda, F Kanzawa, N Saijo, K Nishio.   

Abstract

Vinorelbine (Navelbine, KW-2307), a semisynthetic vinca alkaloid, is a potent inhibitor of mitotic microtubule polymerization. The aims of this study were to demonstrate radiosensitization produced by vinorelbine in human non-small cell lung cancer (NSCLC) PC-9 cells and to elucidate the cellular mechanism of radiosensitization. A clonogenic assay demonstrated that PC-9 cells were sensitized to radiation by vinorelbine with a maximal sensitizer enhancement ratio at a 10% cell survival level of 1.35 after 24-h exposure to vinorelbine at 20 nM. After 24-h exposure to vinorelbine at 20 nM, the approximately 67% of the cells that had accumulated in the G2/M-phase were cultured in the absence of vinorelbine and then irradiated at a dose of 8 Gy. Flow cytometric analyses showed prolonged G2/M accumulation concomitant with continuous polyploidization, and induction of apoptosis was observed in the cells subjected to the combination of vinorelbine-pretreatment and radiation. Polyploidization and induction of apoptosis were confirmed by morphological examination and a DNA fragmentation assay, respectively. We concluded that vinorelbine at a minimally toxic concentration moderately sensitizes human NSCLC cells to radiation by causing accumulation of cells in the G2/M-phase of the cell cycle. Prolonged G2/M accumulation concomitant with continuous polyploidization and increased susceptibility to induction of apoptosis may be associated with the cellular mechanism of radiosensitization produced by vinorelbine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714543     DOI: 10.1016/s0169-5002(01)00265-3

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  11 in total

1.  Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer.

Authors:  Masashi Kobayashi; Kaoru Matsui; Tomonori Hirashima; Takashi Nitta; Shinji Sasada; Takuhito Tada; Kazuo Minakuchi; Mitsugi Furukawa; Yoshitaka Ogata; Ichiro Kawase
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 2.  Pharmacotherapy options for locally advanced and advanced cervical cancer.

Authors:  Alfonso Dueñas-González; Lucely Cetina; Jaime Coronel; Déborah Martínez-Baños
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

3.  Radiosensitizers in cervical cancer. Cisplatin and beyond.

Authors:  Myrna Candelaria; Alicia Garcia-Arias; Lucely Cetina; Alfonso Dueñas-Gonzalez
Journal:  Radiat Oncol       Date:  2006-05-08       Impact factor: 3.481

4.  The role of apoptotic cell death in the radiosensitising effect of gemcitabine.

Authors:  B Pauwels; J B Vermorken; A Wouters; J Ides; S Van Laere; H A J Lambrechts; G G O Pattyn; K Vermeulen; P Meijnders; F Lardon
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

5.  Tumor burden talks in cancer treatment with PEGylated liposomal drugs.

Authors:  Yi-Yu Lin; Hao-Wen Kao; Jia-Je Li; Jeng-Jong Hwang; Yun-Long Tseng; Wuu-Jyh Lin; Ming-Hsien Lin; Gann Ting; Hsin-Ell Wang
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

6.  Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.

Authors:  Cindy Simoens; Filip Lardon; Bea Pauwels; Christel M J De Pooter; Hilde A J Lambrechts; Greet G O Pattyn; Fabienne Breillout; Jan B Vermorken
Journal:  BMC Cancer       Date:  2008-02-29       Impact factor: 4.430

7.  Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma.

Authors:  Toshirou Fukushima; Kazunari Tateishi; Masayuki Hanaoka; Keiichirou Koiwai; Shigeru Sasaki; Tomonobu Koizumi
Journal:  Case Rep Oncol       Date:  2014-01-24

Review 8.  Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer.

Authors:  Francesco Perri; Grazia Lazzari; Giuseppina Della Vittoria Scarpati; Giovanni Silvano
Journal:  Onco Targets Ther       Date:  2016-04-19       Impact factor: 4.147

9.  Anti-apoptotic effects of autophagy via ROS regulation in microtubule-targeted and PDGF-stimulated vascular smooth muscle cells.

Authors:  Hyun-Soo Park; Joo-Hui Han; Sang-Hyuk Jung; Do-Hyung Lee; Kyung-Sun Heo; Chang-Seon Myung
Journal:  Korean J Physiol Pharmacol       Date:  2018-04-25       Impact factor: 2.016

10.  Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma.

Authors:  Kheng Wei Yeoh; Aldo Prawira; Muhammad Zafrie Bin Saad; Kok Ming Lee; Eric Ming Hon Lee; Gee Keng Low; Mohamed Hakim Bin Mohd Nasir; Jun Hao Phua; Wendy Wan Li Chow; Iris Jiu Hia Lim; Yusnita Binte Omar; Rebecca Zhi Wen Ho; Thi Bich Uyen Le; Thanh Chung Vu; Khee Chee Soo; Hung Huynh
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.